Sarepta Therapeutics, Inc.
|
2,558,478
|
$76,217,000
|
7.48%
|
-320,501
|
+$7,035,000
|
NEUROCRINE BIOSCIENCES INC
|
4,599,867
|
$68,262,000
|
6.70%
|
-19,500
|
-$6,110,000
|
ACELRX PHARMACEUTICALS INC
|
6,574,060
|
$67,384,000
|
6.61%
|
No Change
|
-$11,570,000
|
VERTEX PHARMACEUTICALS INC / MA
|
470,142
|
$44,513,000
|
4.37%
|
-111,586
|
+$3,373,000
|
Celgene Corp
|
507,488
|
$43,580,000
|
4.28%
|
+301,288
|
+$14,794,000
|
TARO PHARMACEUTICAL INDUSTRIES LTD
|
301,333
|
$42,260,000
|
4.15%
|
+204,322
|
+$31,492,000
|
AMICUS THERAPEUTICS, INC.
|
12,339,444
|
$41,214,000
|
4.04%
|
+11,373,144
|
+$39,214,000
|
Questcor Pharmaceuticals Inc
|
400,000
|
$36,996,000
|
3.63%
|
+371,400
|
+$35,139,000
|
INSMED Inc
PAR $.01
|
1,800,000
|
$35,964,000
|
3.53%
|
New
|
+$35,964,000
|
Dyax Corp
|
2,710,598
|
$26,022,000
|
2.55%
|
+147,924
|
+$3,009,000
|
ZIMMER BIOMET HOLDINGS, INC.
|
242,500
|
$25,186,000
|
2.47%
|
New
|
+$25,186,000
|
SHIRE PLC
SPONSORED ADR
|
90,000
|
$21,194,000
|
2.08%
|
New
|
+$21,194,000
|
Walgreen Co
|
282,000
|
$20,905,000
|
2.05%
|
-22,419
|
+$804,000
|
Xencor Inc
|
1,740,621
|
$20,226,000
|
1.98%
|
+251,949
|
+$2,764,000
|
HERON THERAPEUTICS, INC. /DE/
|
1,634,555
|
$20,138,000
|
1.98%
|
-127,871
|
-$4,377,000
|
Tesaro Inc
|
636,956
|
$19,816,000
|
1.94%
|
-593,114
|
-$16,446,000
|
LION BIOTECHNOLOGIES
|
3,011,549
|
$19,273,000
|
1.89%
|
+11,549
|
-$9,047,000
|
NEPTUNE TECHNOLOGIES BIORESO
|
6,700,444
|
$18,493,000
|
1.81%
|
No Change
|
+$1,943,000
|
PTC THERAPEUTICS, INC.
|
671,736
|
$17,559,000
|
1.72%
|
No Change
|
+$1,000
|
IVERIC bio, Inc.
|
371,469
|
$15,717,000
|
1.54%
|
+121,469
|
+$6,782,000
|
EXACT SCIENCES CORP
|
901,250
|
$15,348,000
|
1.51%
|
-923,900
|
-$10,514,000
|
Retrophin, Inc.
|
1,274,292
|
$14,960,000
|
1.47%
|
+230,000
|
-$7,178,000
|
ACADIA PHARMACEUTICALS INC
|
653,000
|
$14,751,000
|
1.45%
|
-13,000
|
-$1,453,000
|
MYLAN INC
|
282,500
|
$14,566,000
|
1.43%
|
+50,000
|
+$3,213,000
|
Relypsa Inc
|
596,605
|
$14,509,000
|
1.42%
|
+415,405
|
+$9,107,000
|